Brought to you by

Serologicals acquires Upstate Group for $205mm
28 Sep 2004
Executive Summary
To increase its presence in the kinase screening and protein interaction fields, Serologicals has acquired private company Upstate Group Inc. (cell signaling reagents for life science and drug discovery) in a $205mm cash and stock transaction.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
- Molecular Diversity
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com